These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 16087865)
1. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865 [TBL] [Abstract][Full Text] [Related]
2. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice. Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693 [TBL] [Abstract][Full Text] [Related]
3. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy. Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330 [TBL] [Abstract][Full Text] [Related]
5. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N Cell Immunol; 2000 Jun; 202(2):97-102. PubMed ID: 10896769 [TBL] [Abstract][Full Text] [Related]
6. Two genetic loci independently confer susceptibility to autoimmune gastritis. Ang DK; Brodnicki TC; Jordan MA; Wilson WE; Silveira P; Gliddon BL; Baxter AG; van Driel IR Int Immunol; 2007 Sep; 19(9):1135-44. PubMed ID: 17698560 [TBL] [Abstract][Full Text] [Related]
7. T cell receptor gene polymorphisms associated with anti-insulin, autoimmune T cells in diabetes-prone NOD mice. Simone EA; Yu L; Wegmann DR; Eisenbarth GS J Autoimmun; 1997 Jun; 10(3):317-21. PubMed ID: 9218760 [TBL] [Abstract][Full Text] [Related]
8. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720 [TBL] [Abstract][Full Text] [Related]
9. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model. Hung JT; Liao JH; Lin YC; Chang HY; Wu SF; Chang TH; Kung JT; Hsieh SL; McDevitt H; Sytwu HK J Autoimmun; 2005 Nov; 25(3):181-92. PubMed ID: 16263243 [TBL] [Abstract][Full Text] [Related]
10. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066 [TBL] [Abstract][Full Text] [Related]
11. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Jaeckel E; Lipes MA; von Boehmer H Nat Immunol; 2004 Oct; 5(10):1028-35. PubMed ID: 15378058 [TBL] [Abstract][Full Text] [Related]
12. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843 [TBL] [Abstract][Full Text] [Related]
13. Autoantibody patterns in diabetes-prone NOD mice and in standard C57BL/6 mice. Quintana FJ; Cohen IR J Autoimmun; 2001 Nov; 17(3):191-7. PubMed ID: 11712856 [TBL] [Abstract][Full Text] [Related]
14. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081 [TBL] [Abstract][Full Text] [Related]
15. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. Ogawa N; Minamimura K; Kodaka T; Maki T J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179 [TBL] [Abstract][Full Text] [Related]
16. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140 [TBL] [Abstract][Full Text] [Related]
17. Idd-linked genetic regulation of TACIhigh expressing B cells in NOD mice. Sundström M; Lejon K J Autoimmun; 2007; 29(2-3):116-24. PubMed ID: 17656068 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice. Chiu PP; Ivakine E; Mortin-Toth S; Danska JS Cancer Res; 2002 Oct; 62(20):5828-34. PubMed ID: 12384545 [TBL] [Abstract][Full Text] [Related]
19. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes. Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119 [TBL] [Abstract][Full Text] [Related]
20. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Silveira PA; Grey ST Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]